Literature DB >> 221550

Viral exposure and abnormal liver function in haemophilia.

B A McVerry, M G Ross, W A Knowles, J Voke.   

Abstract

Several studies have recently documented the presence of persistently abnormal liver function tests in asymptomatic haemophiliacs. While the aetiology is unknown it is possible that repeated exposure to agents transmitted in blood products may be important. This study has attempted to determine the prevalence of viral exposure and its relationship to liver function in this multitransfused group of individuals. The prevalence of viral antibodies with the exception of antibody to hepatitis B surface antigen (anti-HBs) and cytomegalovirus (CMV) was normal when compared to that in the general population. Hepatitis B surface antigen (HBsAg) was not detected, but anti-HBs was found in 83% of patients; 50% of patients had abnormal liver function. However, liver function tests were normal in all patients with mild haemophilia and were only rarely abnormal in patients who had no detectable antibody to CMV, Epstein-Barr virus (EBV), and HBsAg. This study demonstrates that multiple transfusions of blood products, that is, cryoprecipitate and factor concentrates, do not increase the risk of exposure to the viruses studied with the exception of hepatitis B virus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221550      PMCID: PMC1145676          DOI: 10.1136/jcp.32.4.377

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors:  C M BRADSTREET; C E TAYLOR
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1962-05

2.  Chronic liver dysfunction in multitransfused hemophiliacs.

Authors:  U W Hasiba; J A Spero; J H Lewis
Journal:  Transfusion       Date:  1977 Sep-Oct       Impact factor: 3.157

3.  Asymptomatic structural liver disease in hemophilia.

Authors:  J A Spero; J H Lewis; D H Van Theil; U Hasiba; B S Rabin
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

4.  Liver dysfunction in patients with hemophilia A, B, and von Willebrand's disease.

Authors:  M W Hilgartner; P Giardina
Journal:  Transfusion       Date:  1977 Sep-Oct       Impact factor: 3.157

5.  Liver biopsy in hemophilia A.

Authors:  H R Lesesne; J E Morgan; P M Blatt; W P Webster; H R Roberts
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

6.  Health of the intensively treated hemophiliac, with special reference to abnormal liver chemistries and splenomegaly.

Authors:  P H Levine; B A McVerry; B Attock; K M Dormandy
Journal:  Blood       Date:  1977-07       Impact factor: 22.113

7.  Antibody to hepatitis B surface antigen in haemophiliacs on long-term therapy with Scottish factor VIII.

Authors:  C J Burrell; S H Black; D M Ramsay
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

8.  Immune complexes and abnormal liver function in haemophilia.

Authors:  B A McVerry; J Voke; I Mohammed; K M Dormandy; E J Holborow
Journal:  J Clin Pathol       Date:  1977-12       Impact factor: 3.411

9.  Jaundice and hepatitis B surface antigen and antibody in Greek haemophiliacs.

Authors:  A Yannitsiotis; I Bossinakou; C Louizou; T Mandalaki
Journal:  Scand J Haematol Suppl       Date:  1977

10.  Modifications of factor VIII related antigen in hemophiliacs with acute hepatitis and sub-clinical liver disease.

Authors:  Y Sultan; P Maisonneuve; J Simeon; L Intrator
Journal:  Scand J Haematol Suppl       Date:  1977
View more
  3 in total

1.  Liver disease complicating severe haemophilia in childhood.

Authors:  K M McGrath; J S Lilleyman; D R Triger; J C Underwood
Journal:  Arch Dis Child       Date:  1980-07       Impact factor: 3.791

2.  Coagulation factor therapy for hemophilia: relation to hepatitis B and to liver function.

Authors:  R T Card; M Dusevic; B E Lukie
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

3.  Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland.

Authors:  Marta Kucharska; Malgorzata Inglot; Aleksandra Szymczak; Weronika Rymer; Malgorzata Zalewska; Krzysztof Malyszczak; Urszula Zaleska-Dorobisz; Malgorzata Kuliszkiewicz-Janus
Journal:  Hepat Mon       Date:  2016-07-23       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.